Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2023-05-18 00:00:00 ET · period of report 2023-05-16 · accession 0001209191-23-030857 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-18 | 2023-05-16 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.1 | +25.0K | 57.4K | +77% | +$2,500 |
| D | 2023-05-18 | 2023-05-16 | TMCI | Scanlan Sean F. | Chief Innovation Off | S - Sale+OE | $25.44 | -25.0K | 32.4K | -44% | -$636.0K |
| D | 2023-05-18 | 2023-05-16 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.00 | -25.0K | 33.8K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-16 | M | A | 25,000 | $0.1 | 57,395 | D | — | — | (F2) Includes 31,256 RSUs. |
| 2 | Common | Common Stock | 2023-05-16 | S | D | 25,000 | $25.44 | 32,395 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0600 to $25.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes 31,256 RSUs. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-05-16 | M | D | 25,000 | $0.00 | 33,750 | D | $0.1 · 2018-12-15 to 2024-12-15 | 25,000 Common Stock | (F4) The stock option vested in equal annual installments over 4 years, commencing on December 15, 2015 with the last installment vesting on December 15, 2018. |